Cerebral Infarction Treatment Market Analysis Report 2025-2030: Hospital Pharmacies Capture 63.6% of Cerebral Infarction Treatment Distribution in 2024 [Yahoo! Finance]
Amgen Inc. (AMGN)
Last amgen inc. earnings: 4/30 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.amgen.com
Company Research
Source: Yahoo! Finance
Drug Class (Anticoagulants, Antiplatelets), By Type (Ischemic Stroke), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030" report has been added to ResearchAndMarkets.com's offering. This comprehensive analysis provides in-depth insights into the evolving landscape of cerebral infarction treatments worldwide.? The global cerebral infarction treatment market is projected to reach USD 20.51 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.4% from 2025 to 2030. This growth is primarily driven by the increasing prevalence of ischemic strokes, attributed to an aging global population and rising incidences of lifestyle-related risk factors such as hypertension and diabetes.? Key Insights Prevalence of Ischemic Stroke : In 2024, the ischemic stroke segment held the largest market share at 78.6%, underscoring the high incidence of this condition and the critical need for effective treatments.? Dominance of Tissue Plasminogen Activators (tPA):
Show less
Read more
Impact Snapshot
Event Time:
AMGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AMGN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AMGN alerts
High impacting Amgen Inc. news events
Weekly update
A roundup of the hottest topics
AMGN
News
- AMGEN TAKES ACTION WITH THE U.S. GOVERNMENT TO LOWER THE COST OF MEDICINES FOR AMERICAN PATIENTS [Yahoo! Finance]Yahoo! Finance
- AMGEN TAKES ACTION WITH THE U.S. GOVERNMENT TO LOWER THE COST OF MEDICINES FOR AMERICAN PATIENTSPR Newswire
- HSBC Turns More Bullish on Amgen (AMGN) into 2026 [Yahoo! Finance]Yahoo! Finance
- Exploring Growth Trends in the Chemotherapy Induced Anemia Market: A Surge to USD 4.84 Billion by 2032 [Yahoo! Finance]Yahoo! Finance
- Amgen (NASDAQ:AMGN) was upgraded by analysts at <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=AMGN&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall Street Zen</a> fromMarketBeat
AMGN
Earnings
- 11/4/25 - Beat
AMGN
Sec Filings
- 11/21/25 - Form 4
- 11/20/25 - Form 144
- 11/13/25 - Form 4
- AMGN's page on the SEC website